Oxygea

Oxygea's leadership and investment committee structure have not been publicly detailed. The firm operates as the venture arm of the Gradin family office, with decisions likely resting with senior family principals and a dedicated investment team based in São Paulo. Specific named leads have not been disclosed in public record.

Oxygea is a single-family office deploying the Gradin family's proprietary capital, but it behaves like a specialized venture firm. It maintains a dedicated brand, three offices on different continents, and a focused investment strategy around industrial and climate technologies. It does not raise outside capital or manage third-party limited partner commitments.

Oxygea was created by the Gradin family, whose patriarch founded Braskem in 2002 and built it into the largest petrochemical company in the Americas. Oxygea invests in ventures that can integrate with or benefit from Braskem's production infrastructure, supply chains, and customer networks, making it a strategic extension of the family's industrial assets even though the two entities are legally distinct.

Oxygea targets early-stage investments from Seed through Series B. It focuses on companies developing advanced materials, bio-based chemicals, carbon capture technologies, industrial AI, and circular-economy solutions that have the potential to scale within Latin American and global petrochemical supply chains.

The Gradin family's wealth originates from Braskem, the petrochemical company founded in 2002 and now majority-controlled by Novonor (formerly Odebrecht) and Petrobras. The family has held a significant equity stake in Braskem for decades and remains one of the primary controlling shareholders.

There is no public record of philanthropic foundations or impact-focused vehicles formally separated from Oxygea's investment operations. The firm's climate-tech and circular-economy mandate sits within its for-profit venture portfolio, not a donor-advised or grant-making structure.

Oxygea regularly co-invests alongside institutional venture capital and corporate venture arms, including in rounds for UBQ Materials and Nexus Circular. The firm participates in syndicated venture rounds while contributing strategic value through Braskem's industrial footprint. It does not publicly list co-investment partners as a formal club or consortium structure.